<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>How SAGE helps you comply with the FDA's SaMD guidelines</title>
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <nav class="navbar">
        <div class="nav-container">
            <a href="/SAGE/" class="nav-logo">SAGE</a>
            <div class="nav-links">
                <a href="/SAGE/">Home</a>
                <a href="/SAGE/solution.html">Our Solution</a>
                <a href="/SAGE/blog.html">Blog</a>
                <a href="/SAGE/docs.html">Docs</a>
                <a href="/SAGE/contact.html">Contact</a>
            </div>
        </div>
    </nav>

    <div class="container">
        <article class="blog-post">
            <header class="post-header">
                <h1>How SAGE helps you comply with the FDA's SaMD guidelines</h1>
            </header>

            <div class="post-content">
                <p>Non-compliance with FDA regulations for Software as a Medical Device (SaMD), including AI-based applications, can result in severe penalties, including:</p>
                <ul>
                    <li><strong>Product Recall:</strong> Mandatory removal of non-compliant software from the market.</li>
                    <li><strong>Fines:</strong> Financial penalties based on the severity and impact of the violation.</li>
                    <li><strong>Warning Letters:</strong> Official FDA notices that damage reputation and require immediate corrective actions.</li>
                    <li><strong>Injunctions:</strong> Court orders halting the distribution or development of the software.</li>
                    <li><strong>Criminal Prosecution:</strong> In cases of intentional or egregious violations, individuals or companies may face criminal charges.</li>
                </ul>
                <p>Compliance ensures patient safety, market access, and credibility. SAGE helps organizations comply with FDA guidelines when developing, modifying, and deploying internally-developed CDS (Clinical Decision Support) software determined to be devices according to FDA guidelines. <a href="https://www.fda.gov/medical-devices/digital-health-center-excellence/step-1-software-function-intended-medical-purpose" target="_blank">FDA Tool for Determining Device Status</a>.</p>

                <h2>How SAGE Supports Compliance</h2>

                <h3>1. Risk-Based Framework</h3>
                <p><strong>FDA Guideline:</strong> SaMD is categorized based on the risk to patients if it malfunctions, using IMDRF's framework:</p>
                <ul>
                    <li><strong>Significance of Information:</strong> Drives or informs clinical management decisions.</li>
                    <li><strong>Healthcare Condition:</strong> Critical, serious, or non-serious conditions.</li>
                </ul>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Risk Assessment Tools: Use ISO 14971 to evaluate and document hazards.</li>
                    <li>Software Categorization: Classify software by risk (e.g., Class II or III for higher risk requiring FDA approval).</li>
                    <li>Failure Mode Analysis: Identify and mitigate potential failure impacts.</li>
                </ul>

                <h3>2. Software Life Cycle</h3>
                <p><strong>FDA Guideline:</strong> Robust development and maintenance practices are required to ensure software performance throughout its lifecycle.</p>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Development Standards: Follow IEC 62304 for design, development, and testing.</li>
                    <li>Validation: Establish automated and manual validation processes.</li>
                    <li>Configuration Management: Track changes to code, requirements, and documentation.</li>
                    <li>Change Control: Document and assess updates or bug fixes.</li>
                </ul>

                <h3>3. Clinical Evaluation</h3>
                <p><strong>FDA Guideline:</strong> SaMD must demonstrate performance through analytical and clinical validation.</p>
                <ul>
                    <li><strong>Analytical Validation:</strong> Ensures technical performance as specified.</li>
                    <li><strong>Clinical Validation:</strong> Confirms accurate and beneficial results for the intended use.</li>
                </ul>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Test Data: Evaluate datasets for validation and assess for bias.</li>
                    <li>Performance Metrics: Establish measures like sensitivity, specificity, accuracy, and precision.</li>
                    <li>Regulatory Submission: Compile results for FDA 510(k) or PMA submissions.</li>
                </ul>

                <h3>4. Transparency and Explainability</h3>
                <p><strong>FDA Guideline:</strong> Complex algorithms, including AI, must be interpretable to ensure trust and proper usage.</p>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Explainability Methods: Use interpretable AI models and visual explanations for outputs.</li>
                    <li>User Training: Provide materials to explain limitations and proper usage.</li>
                    <li>Labeling Requirements: Include user manuals, warnings, and intended use details.</li>
                </ul>

                <h3>5. Cybersecurity</h3>
                <p><strong>FDA Guideline:</strong> SaMD must ensure data protection and operational integrity against cyber threats.</p>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Encryption Checking: Verify data encryption in transit and at rest using DPIAs.</li>
                    <li>Access Controls: Ensure role-based access and multi-factor authentication.</li>
                    <li>Security Standards: Use NIST Cybersecurity Framework and FDA cybersecurity guidance.</li>
                    <li>Penetration Testing: Schedule regular testing for vulnerabilities and remediate them.</li>
                </ul>

                <h3>6. Post-Market Surveillance</h3>
                <p><strong>FDA Guideline:</strong> Continuous monitoring is required to maintain safety and effectiveness after launch.</p>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li>Real-Time Monitoring: Detect and report errors or malfunctions promptly.</li>
                    <li>Adverse Event Reporting: Utilize FDA's MAUDE database for issue tracking.</li>
                    <li>Feedback Loops: Gather user feedback to improve usability and safety.</li>
                    <li>Periodic Updates: Release patches for vulnerabilities and performance improvements.</li>
                </ul>

                <h3>7. Change Management</h3>
                <p><strong>FDA Guideline:</strong> AI/ML-based SaMD requires transparency, real-world performance monitoring, and periodic reporting on updates to the FDA. Changes made to approved devices need to be tested, documented, and monitored.</p>
                <p><strong>SAGE Controls:</strong></p>
                <ul>
                    <li><strong>Data Management:</strong> Implement collection protocols and quality assurance measures for new training and test data.</li>
                    <li>Determine reference standards and ensure auditing and sequestration of training and test sets.</li>
                    <li><strong>Re-Training:</strong> Define objectives and document changes related to machine learning methods and data pre-processing.</li>
                    <li>Establish criteria to initiate performance evaluation.</li>
                    <li><strong>Performance Evaluation:</strong> Define assessment metrics, statistical analysis plans, and performance targets.</li>
                    <li>Schedule evaluations based on frequency and triggers.</li>
                    <li>Use "clinicians in the loop" for testing when necessary.</li>
                    <li><strong>Update Procedures:</strong> Verify and validate software updates.</li>
                    <li>Plan for global and local updates with clear timelines.</li>
                    <li>Communicate changes transparently to users and stakeholders.</li>
                </ul>
            </div>
        </article>
    </div>

    <footer>
        <div class="footer-content">
            <div>
                <h3>SAGE</h3>
                <p>Making AI governance accessible for healthcare</p>
            </div>
            <div>
                <h3>Contact</h3>
                <p>Email: contact@sage.org</p>
            </div>
        </div>
    </footer>
</body>
</html>
